Quantum BioPharma hits midpoint in mass general imaging study for multiple sclerosis
Quantum BioPharma (NASDAQ:QNTM) has reached the halfway enrollment mark in its collaborative clinical study with Massachusetts General Hospital (MGH), yielding encouraging preliminary imaging data.










